Understanding Cod Liver Oil: Composition and History

Cod liver oil is a nutrient-dense supplement extracted from the liver of Atlantic cod (Gadus morhua). For centuries, it has been a mainstay in traditional medicine, valued for its rich supply of long-chain omega-3 fatty acids—specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—as well as fat-soluble vitamins A and D. The oil’s historical use dates back to Viking times, and by the 18th century it was widely recommended in Europe for preventing and treating rickets, a bone disease caused by vitamin D deficiency. Today, cod liver oil remains popular for supporting cardiovascular health, cognitive function, joint mobility, and immune response. But growing interest has turned to its potential role in metabolic health, particularly for blood glucose management in individuals with type 2 diabetes or insulin resistance.

The unique composition of cod liver oil sets it apart from other fish oils. One teaspoon (5 ml) typically provides around 450–500 mg of EPA and DHA combined, plus 400–500 mcg of vitamin A and 10–20 mcg (400–800 IU) of vitamin D. The presence of these vitamins introduces both benefits and caution: while vitamin A is essential for vision and immune function, excessive intake can accumulate to toxic levels. Vitamin D, on the other hand, is critical for calcium absorption and has been linked to improved insulin sensitivity. Because the ratio of vitamins to omega-3s is higher in cod liver oil than in regular fish oil, it is important to understand how these components interact in the context of glucose metabolism.

The omega-3 fatty acids EPA and DHA are celebrated for their anti-inflammatory properties. Chronic low-grade inflammation is a well-established contributor to insulin resistance—a condition in which cells fail to respond properly to insulin, leading to elevated blood glucose levels. By reducing inflammatory mediators such as cytokines and prostaglandins, omega-3s may help restore insulin signaling pathways. A 2022 systematic review and meta-analysis of randomized controlled trials found that supplementation with marine omega-3s significantly reduced fasting insulin and improved the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) scores in adults with type 2 diabetes or metabolic syndrome.

Mechanisms of Action

Several biological mechanisms explain how cod liver oil’s omega-3s could support glycemic control:

  • Enhanced insulin sensitivity: Omega-3s incorporate into cell membranes, increasing their fluidity and improving insulin receptor function. This allows glucose to enter cells more efficiently.
  • Reduced inflammation: EPA and DHA inhibit the production of pro-inflammatory molecules like tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which are known to interfere with insulin signaling.
  • Improved pancreatic beta-cell function: Some animal studies suggest that DHA protects pancreatic islet cells from oxidative stress, potentially preserving insulin secretion capacity.
  • Modulation of adipokines: Omega-3s may positively influence leptin and adiponectin levels, hormones that regulate appetite and glucose metabolism.

Research Overview

The evidence for omega-3s alone is substantial, but cod liver oil adds vitamins A and D to the equation, which may produce synergistic effects. A notable 2017 study published in the Journal of Diabetes Investigation examined adults with prediabetes who took a daily cod liver oil supplement for 12 weeks. The treatment group showed a modest but statistically significant reduction in fasting blood glucose and HbA1c compared to placebo. However, not all studies have been consistent. A 2020 trial in the British Journal of Nutrition found no significant change in glycemic markers among overweight individuals who consumed cod liver oil, although inflammatory markers did improve. These conflicting results underscore the need for larger, longer-term investigations.

The Role of Vitamin D in Glucose Metabolism

Vitamin D deficiency has been epidemiologically linked to a higher risk of type 2 diabetes and impaired glucose tolerance. The vitamin D receptor (VDR) is expressed on pancreatic beta cells and in peripheral insulin-sensitive tissues, suggesting a direct role. Binding of active vitamin D (calcitriol) to VDR influences insulin gene transcription and calcium flux necessary for insulin release. Additionally, vitamin D may enhance insulin sensitivity by stimulating the expression of insulin receptors and reducing inflammation. A 2021 meta-analysis of 40 randomized trials concluded that vitamin D supplementation significantly reduced fasting glucose and HbA1c in participants with diabetes or prediabetes, especially those with baseline deficiency.

Cod liver oil provides a natural, bioavailable source of vitamin D3 (cholecalciferol), the same form produced by sun exposure. One teaspoon typically supplies 400–800 IU, which can contribute meaningfully to daily requirements—particularly in regions with limited sunlight or during winter months. However, relying solely on cod liver oil to correct a severe vitamin D deficiency is not recommended, as the amount of oil required to reach therapeutic doses of vitamin D could lead to excessive vitamin A intake. A blood test is advisable before initiating high-dose supplementation.

Key Research Studies on Cod Liver Oil and Blood Sugar

To date, clinical research on cod liver oil specifically (as opposed to generic fish oil) remains limited but informative. Below is a synthesis of major findings organized by outcome.

Positive Findings

  • A 2015 randomized trial involving 80 adults with type 2 diabetes assigned participants to receive either cod liver oil (10 ml/day) or a placebo for 12 weeks. The cod liver oil group experienced a significant decrease in fasting blood glucose (mean reduction of 12 mg/dL), along with improvements in triglyceride levels and HDL cholesterol. Researchers attributed the benefits to the combined actions of omega-3s and vitamins D and A.
  • An observational cohort study published in Diabetes Care (2013) tracked over 8,000 middle-aged and older men for 15 years. Those who reported regular cod liver oil use had a 23% lower incidence of type 2 diabetes compared to non-users, even after adjusting for lifestyle factors such as diet and physical activity.
  • A 2020 pilot study in Nutrition & Metabolism examined the effects of cod liver oil on gestational diabetes risk. Pregnant women who took cod liver oil from the 12th week of gestation showed improved glucose tolerance test results and lower fasting insulin levels at 28 weeks compared to controls.

Mixed or Null Results

  • Not all research points to clear benefits. A 2018 crossover trial published in PLOS ONE gave cod liver oil (5 ml/day) to overweight volunteers with normal glucose tolerance for eight weeks. The oil did not improve fasting glucose, insulin, or HOMA-IR, though it did reduce markers of inflammation (CRP, IL-6). This suggests that cod liver oil may be more effective in individuals who already have impaired glucose metabolism.
  • A 2019 study in European Journal of Clinical Nutrition included participants with well-controlled type 2 diabetes. After six months of cod liver oil supplementation, HbA1c and fasting glucose remained unchanged. The authors hypothesised that the participants’ already-optimized medication regimes may have masked any supplementary effect.

Limitations of Current Research

Most existing studies are small (20–120 participants) and short-term (8–24 weeks), making it difficult to draw definitive conclusions about long-term glycemic control. Dosages vary widely (from 5 ml to 30 ml daily), and the specific ratios of EPA:DHA differ between brands. Additionally, many trials fail to account for participants’ baseline vitamin D status or omega-3 intake from other dietary sources. Pooled analyses are complicated by the fact that cod liver oil is often tested against a placebo oil (e.g., olive oil), which itself may have mild anti-inflammatory effects. Head-to-head comparisons with purified EPA/DHA supplements are still lacking.

Practical Considerations for Supplementation

For those considering cod liver oil to support blood glucose management, several factors must be weighed to ensure safe and effective use.

A typical preventive dose is 5–10 ml (one to two teaspoons) per day, providing roughly 1,000–2,000 mg of combined EPA and DHA plus 800–1,600 IU of vitamin D. Higher doses should be reserved for short-term use under medical supervision due to the risk of vitamin A accumulation. Liquid cod liver oil is the traditional form, but softgel capsules are also widely available. Choose products that are molecularly distilled to remove contaminants (mercury, PCBs, dioxins) and that clearly state the EPA/DHA and vitamin content on the label. Refrigeration of the liquid form helps preserve freshness and prevent rancidity, which can produce harmful oxidation byproducts.

Potential Risks and Side Effects

Cod liver oil is generally safe for most adults when taken within recommended amounts. However, chronic intake exceeding 30 ml daily can lead to hypervitaminosis A, causing symptoms such as nausea, dizziness, liver damage, and bone pain. Because vitamin A is stored in the body, toxicity develops over time. Individuals with liver disease, kidney disorders, or a history of pancreatitis should be particularly cautious. Common minor side effects include fishy aftertaste, belching, heartburn, and loose stools. Taking the oil with meals or freezing the capsules can mitigate these issues. Allergy to cod or other fish is an absolute contraindication.

Interactions with Diabetes Medications

Cod liver oil can theoretically enhance the effects of blood-glucose-lowering medications (e.g., metformin, sulfonylureas, insulin), increasing the risk of hypoglycemia. Patients should monitor blood sugar more closely when starting supplementation and discuss dosage adjustments with their healthcare provider. The oil also has mild anticoagulant properties due to its omega-3 content; combined use with blood thinners like warfarin (Coumadin) or aspirin may prolong bleeding time. A baseline coagulation screen and periodic INR checks are recommended for those on anticoagulant therapy. Vitamin K content is negligible in cod liver oil but should still be mentioned for completeness.

Integrating Cod Liver Oil into a Diabetes Management Plan

No supplement can replace the pillars of diabetes care: a balanced diet, regular physical activity, medication adherence, and blood glucose monitoring. Cod liver oil may act as a supportive adjunct. To optimize benefits, consider the following strategies:

  • Pair with a low-glycemic diet: Omega-3s work best in concert with a diet rich in fiber, lean protein, and healthy fats from sources like avocados, nuts, and olive oil. Avoid high-sugar processed foods that directly raise blood glucose and promote inflammation.
  • Check vitamin D levels: Request a serum 25-hydroxyvitamin D test before starting cod liver oil. If deficient, your doctor may recommend a separate high-dose vitamin D supplement initially, then maintenance with cod liver oil.
  • Adopt consistent timing: Take cod liver oil with a meal containing fat to improve absorption of the oil-soluble vitamins. Morning doses may be easier to remember, but splitting into two smaller doses (e.g., with breakfast and dinner) can reduce GI discomfort.
  • Monitor inflammatory markers: Periodic testing of high-sensitivity CRP (hs-CRP) can help assess whether the anti-inflammatory benefits are being achieved. Lowering hs-CRP is associated with improved insulin sensitivity over time.
  • Consult a registered dietitian or endocrinologist: A professional can tailor the dosage and address potential nutrient interactions. This is especially important for pregnant women, children, and older adults, who have different safety windows for vitamins A and D.

While waiting for more robust clinical trials, observational data and mechanistic plausibility support the prudent use of cod liver oil as part of a comprehensive approach to glucose management. Future research should focus on long-term outcomes, optimal dosing in different populations (e.g., prediabetes vs. established diabetes), and the comparative efficacy of cod liver oil versus standard fish oil supplements. For now, the evidence suggests that cod liver oil is not a stand-alone therapy but a valuable tool that may tip the balance toward better metabolic control, especially when inflammation is a driving factor.

Conclusion

Research indicates that cod liver oil may offer meaningful support for blood glucose management, primarily through its omega-3 fatty acids and vitamin D content. The anti-inflammatory and insulin-sensitizing properties of EPA and DHA, combined with vitamin D’s role in beta-cell function, create a multifaceted rationale for supplementation. However, the existing evidence is far from conclusive, with mixed results across different study populations and dosages. Individuals with diabetes or prediabetes should view cod liver oil as a complementary strategy—not a substitute for established medical and lifestyle interventions.

Before adding cod liver oil to your daily regimen, consult a healthcare provider to assess your specific needs, especially regarding vitamin A safety and potential drug interactions. Used wisely, cod liver oil can be a safe, nutrient-rich addition that supports overall metabolic health. For further reading, refer to the NIH Fact Sheet on Omega-3 Fatty Acids and the Diabetes UK advice on fish and seafood. Ongoing research will continue to clarify the role of cod liver oil in the complex landscape of blood glucose regulation.